Cytokinetics, Incorporated - Common Stock (NQ:CYTK)
70.06
+0.75
(+1.07%)
Streaming Delayed Price
Updated: 11:42 AM EDT, Sep 16, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 227,517 |
| Open | 69.52 |
| Bid (Size) | 70.00 (100) |
| Ask (Size) | 70.11 (200) |
| Prev. Close | 69.31 |
| Today's Range | 69.52 - 70.68 |
| 52wk Range | 47.22 - 88.31 |
| Shares Outstanding | 95,640,600 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Cytokinetics (CYTK) Q2 2026 Earnings Call Transcript ↗
August 13, 2026
Cytokinetics Q2 Earnings Call Highlights ↗
August 06, 2026
Cytokinetics (CYTK) Q1 2026 Earnings Transcript ↗
May 05, 2026
Cytokinetics (CYTK) Q4 2025 Earnings Transcript ↗
February 24, 2026
Frequently Asked Questions
Is Cytokinetics, Incorporated - Common Stock publicly traded?
Yes, Cytokinetics, Incorporated - Common Stock is publicly traded.
What exchange does Cytokinetics, Incorporated - Common Stock trade on?
Cytokinetics, Incorporated - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cytokinetics, Incorporated - Common Stock?
The ticker symbol for Cytokinetics, Incorporated - Common Stock is CYTK on the Nasdaq Stock Market
What is the current price of Cytokinetics, Incorporated - Common Stock?
The current price of Cytokinetics, Incorporated - Common Stock is 70.06
When was Cytokinetics, Incorporated - Common Stock last traded?
The last trade of Cytokinetics, Incorporated - Common Stock was at 09/16/26 11:42 AM ET
What is the market capitalization of Cytokinetics, Incorporated - Common Stock?
The market capitalization of Cytokinetics, Incorporated - Common Stock is 6.70B
How many shares of Cytokinetics, Incorporated - Common Stock are outstanding?
Cytokinetics, Incorporated - Common Stock has 7B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.